Overview
Steptoe’s Federal Circuit win for Sandoz Inc. in a patent dispute over a children’s asthma drug was covered by Law360 in an article titled “Fed. Circ. Affirms Invalidity of AstraZeneca Inhaler Patent.” The article discusses a May 7 decision from the Federal Circuit affirming a lower court’s ruling that invalidated AstraZeneca’s patent on a pediatric asthma inhaler because of obviousness. The court agreed with arguments by Sandoz and two other defendants that decades of examples of sterilized steroids on the market defeated AstraZeneca’s claim that its Pulmicort Respules deserved a patent.
The Steptoe patent litigation team was led by Chicago-based partner Taras Gracey, with associates Thomas Rammer and Gretchen Miller.
The full article can be read at Law360.